Medication, Nutrition, and Hygiene in COVID-19 Prevention and Treatment: A Comprehensive Narrative Review.

Glob Chall · 2025 · PMC12519429 · PMID 41098416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a double‐blind RCT of 1062 hospitalized patients, remdesivir (10‐day regimen) significantly shortened recovery time, improved clinical outcomes, and showed a trend toward lower mortality (11.4% vs 15.2% by day 29) with fewer serious adverse events than placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.